Join
Live feed
·
INSIDERFilingvia Quantisnow
Greenwich LifeSciences Inc. logo

CEO and CFO Patel Snehal bought $79,866 worth of shares (2,900 units at $27.54), increasing direct ownership by 0.05% to 5,602,302 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLSI (Greenwich LifeSciences Inc.) and more on Quantisnow.